Olmesartan Medoxomil Tablet, Coated
Product Images NDC 64980-603

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil (NDC 64980-603). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (E6ab7a82 C142 42b5 B6b4 69b799b52ff9 01)

Chemical structure of Olmesartan Medoxomil, showing its molecular arrangement including rings and functional groups as depicted in the image.*

FDA Label Image

Image (E6ab7a82 C142 42b5 B6b4 69b799b52ff9 02)

A line graph showing the dose-response relationship of Olmesartan Medoxomil tablets on blood pressure reduction. The x-axis represents the dosage in mg (ranging up to 80 mg), and the y-axis represents the reduction in blood pressure in mmHg. Two lines illustrate effects on systolic and diastolic blood pressure, with systolic showing greater reduction at increasing doses compared to diastolic.*

FDA Label Image

Desc (E6ab7a82 C142 42b5 B6b4 69b799b52ff9 03)

Label for Olmesartan Medoxomil Tablets, USP 5 mg by Rising Pharmaceuticals. The label indicates a package containing 30 tablets with an NDC of 64980-601-03. It specifies each tablet contains 5 mg of olmesartan medoxomil, USP. The label includes manufacturer and distributor details, storage instructions, and barcode markings on a white background with blue and yellow design elements.*

FDA Label Image

Desc (E6ab7a82 C142 42b5 B6b4 69b799b52ff9 04)

Label for Olmesartan Medoxomil Tablets, USP 5 mg by Rising Pharma Holdings, Inc. The label shows a quantity of 90 tablets. It includes storage instructions, an NDC number 64980-601-09, and manufacturing details indicating it is made in India by Inventia Healthcare Limited. The label also emphasizes prescription use only (Rx only).*

FDA Label Image

Desc (E6ab7a82 C142 42b5 B6b4 69b799b52ff9 05)

Label for Olmesartan Medoxomil Tablets, USP 20 mg by Rising Pharmaceuticals. The label indicates a package of 30 tablets, with the 20 mg strength highlighted in red. The label includes storage instructions, manufacturing details by Inventia Healthcare Limited in India, distribution by Rising Pharma Holdings, Inc., and an Rx only designation.*

FDA Label Image

Desc (E6ab7a82 C142 42b5 B6b4 69b799b52ff9 06)

Label for Olmesartan Medoxomil Tablets, USP 20 mg, in a 90-tablet package by Rising Pharmaceuticals. The label includes storage instructions, manufacturer details (Inventia Healthcare Limited, India), distributor information (Rising Pharma Holdings, Inc., East Brunswick, NJ), and a barcode. The label also indicates the product is Rx only and contains the NDC 64980-602-09.*

FDA Label Image

Desc (E6ab7a82 C142 42b5 B6b4 69b799b52ff9 07)

Label for Olmesartan Medoxomil Tablets, USP 40 mg by Rising Pharmaceuticals. The label indicates a package size of 30 tablets. It provides storage instructions, manufacturer details for Inventia Healthcare Limited in India, and distributor information for Rising Pharma Holdings, Inc. The label includes barcodes and a prescription-only indication.*

FDA Label Image

Desc (E6ab7a82 C142 42b5 B6b4 69b799b52ff9 08)

Label for Olmesartan Medoxomil Tablets USP 40 mg, containing 90 tablets. The label indicates the active ingredient as olmesartan medoxomil, USP 40 mg, and includes storage instructions. It is manufactured by Inventia Healthcare Limited in India and distributed by Rising Pharma Holdings, Inc. The label includes the NDC 64980-603-09 and notes "Rx only."*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.